SCHEMBL10069515

SCHEMBL10069515

O=C(Cn1nnc(-c2cccc(Cl)c2Cl)n1)NNC(=S)Nc1ccc(Cl)c(Cl)c1

nearest known ligand 0.85

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TASP1 Q9H6P5 1/20 0.85
MAPT P10636 5/20 0.54
ALDH1A1 P00352 4/20 0.54
KDM4E B2RXH2 2/20 0.54
MAPK1 P28482 2/20 0.54
BLM P54132 1/20 0.54
BCL2 P10415 1/20 0.54
BID P55957 1/20 0.54
BCL2L1 Q07817 1/20 0.54
MCL1 Q07820 1/20 0.54
TP53 P04637 1/20 0.52
MEN1 O00255 6/20 0.49
KMT2A Q03164 6/20 0.49
GAA P10253 4/20 0.49
MGAM O43451 1/20 0.49
SI P14410 1/20 0.49
MGAM2 Q2M2H8 1/20 0.49
RAB9A P51151 2/20 0.47
NPC1 O15118 1/20 0.47
HPGD P15428 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10068891 0.92 TASP1 (1.00) TASP1MAPTALDH1A1KDM4EMAPK1
SCHEMBL7922643 0.84 TASP1 (0.62) TASP1MAPTALDH1A1KDM4EMAPK1
SCHEMBL14096399 0.80 TASP1 (0.64) TASP1MAPTALDH1A1KDM4EMAPK1
SCHEMBL14096381 0.77 TASP1 (0.60) TASP1MAPTALDH1A1KDM4EMAPK1
SCHEMBL7920494 0.73 TASP1 (0.56) TASP1MAPTALDH1A1KDM4EMAPK1
SCHEMBL7922259 0.73 TASP1 (0.61) TASP1MAPTALDH1A1KDM4EMAPK1
SCHEMBL7922258 0.68 MAPT (0.48) TASP1MAPTALDH1A1KDM4EMAPK1
SCHEMBL1062494 0.68 TASP1 (0.48) TASP1MAPTALDH1A1KDM4EMAPK1
SCHEMBL29410073 0.68 MAPT (0.54) MAPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL19260918 0.68 MAPT (0.54) MAPTALDH1A1KDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8501811-B2 TASPASE1 inhibitors and their uses WASHINGTON UNIVERSITY (US) 2013-08-06 US disclosed
US-20120015990-A1 TASPASE1 INHIBITORS AND THEIR USES THE WASHINGTON UNIVERSITY (US) 2012-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120015990-A1 TASPASE1 INHIBITORS AND THEIR USES RNASE1, TASP1, PPA1 TASP1 2/4885MAPT 4457/4885ALDH1A1 3123/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.